RNA polymerase II
RNA polymerase II (RNAP II, also known as POLR2 or RPB1) is an enzyme found in eukaryotic cells. It is responsible for transcribing DNA into messenger RNA (mRNA), a critical step in the process of gene expression. This enzyme is essential for the synthesis of mRNA and plays a pivotal role in the regulation of gene expression, making it a key player in cellular function and development.
Structure[edit]
RNA polymerase II is a complex molecule composed of 12 subunits, designated as RPB1 through RPB12. The largest subunit, RPB1, contains a unique carboxy-terminal domain (CTD) that is heavily phosphorylated during the transcription process. This phosphorylation is crucial for the enzyme's activity and its interaction with various transcription factors and RNA processing enzymes.
Function[edit]
The primary function of RNA polymerase II is to transcribe DNA into pre-mRNA. This process involves the unwinding of the DNA helix, the synthesis of RNA using one of the DNA strands as a template, and the eventual re-winding of the DNA. RNA polymerase II is also involved in the processing of pre-mRNA, which includes 5' capping, splicing, and 3' polyadenylation, processes that are essential for the maturation of mRNA.
Regulation[edit]
The activity of RNA polymerase II is tightly regulated through various mechanisms. These include the phosphorylation of the CTD, the interaction with transcription factors and mediator complexes, and the response to cellular signals. Such regulation ensures that genes are expressed at the right time, in the right cell type, and in response to the cellular environment.
Clinical Significance[edit]
Mutations in the genes encoding the subunits of RNA polymerase II can lead to a variety of diseases, including cancers and developmental disorders. Given its central role in gene expression, RNA polymerase II is also a target for certain toxins and drugs that aim to inhibit its activity, thereby controlling disease progression or pathogens that rely on host transcription machinery.
Research and Applications[edit]
Research on RNA polymerase II has provided insights into the fundamental processes of gene expression and regulation. It has also led to the development of novel therapeutic strategies, including the design of drugs that specifically target the transcription machinery in diseases such as cancer.
See Also[edit]
References[edit]
| Transcription (Bacterial, Eukaryotic) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
-
Label RNA pol II
-
RNA polymerase II fcgi
-
Eukaryotic RNA polymerase II structure 1WCM
-
Alpha-Amanitin–RNA polymerase II complex 1K83
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian